[go: up one dir, main page]

IN2013DE03665A - - Google Patents

Download PDF

Info

Publication number
IN2013DE03665A
IN2013DE03665A IN3665DE2013A IN2013DE03665A IN 2013DE03665 A IN2013DE03665 A IN 2013DE03665A IN 3665DE2013 A IN3665DE2013 A IN 3665DE2013A IN 2013DE03665 A IN2013DE03665 A IN 2013DE03665A
Authority
IN
India
Prior art keywords
formula
useful
compound
preparation
cell lines
Prior art date
Application number
Inventor
Kamal Ahmed
Venkata Subba Reddy Narrikolla
Prasad Budaganaboyina
Lakshma Nayak Vadithe
Saidi Reddy Vangala
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Priority to IN3665DE2013 priority Critical patent/IN2013DE03665A/en
Priority to US14/569,173 priority patent/US9309225B2/en
Publication of IN2013DE03665A publication Critical patent/IN2013DE03665A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention provides a compound of general formula 1, useful as potential anticancer agents against human cancer cell lines and process for the preparation thereof. Formula 1
IN3665DE2013 2013-12-16 2013-12-16 IN2013DE03665A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN3665DE2013 IN2013DE03665A (en) 2013-12-16 2013-12-16
US14/569,173 US9309225B2 (en) 2013-12-16 2014-12-12 N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide compounds as potential anticancer agents and a process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3665DE2013 IN2013DE03665A (en) 2013-12-16 2013-12-16

Publications (1)

Publication Number Publication Date
IN2013DE03665A true IN2013DE03665A (en) 2015-06-19

Family

ID=53367618

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3665DE2013 IN2013DE03665A (en) 2013-12-16 2013-12-16

Country Status (2)

Country Link
US (1) US9309225B2 (en)
IN (1) IN2013DE03665A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105764491A (en) 2013-12-09 2016-07-13 度瑞公司 Pharmaceutically active agent complexes, polymer complexes, and compositions and methods comprising the same

Also Published As

Publication number Publication date
US20150166507A1 (en) 2015-06-18
US9309225B2 (en) 2016-04-12

Similar Documents

Publication Publication Date Title
PH12018502535A1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
EP4230264A3 (en) Prodrugs of fumarates and their use in treating various deseases
MX2016002544A (en) Compounds useful as immunomodulators.
IN2015DN00598A (en)
MX2015007097A (en) Novel bi-ring phenyl-pyridines/pyrazines for the treatment of cancer.
MX361499B (en) Deuterated baricitinib.
MX2016016143A (en) Substituted [1,2,4]triazole compounds.
PH12014502032A1 (en) Treatment of brain cancer
MX2015008829A (en) Deuterated momelotinib.
JO3372B1 (en) 5-benzylisoquinoleine derivatives for the treatment of cardiovascular diseases
ZA201803476B (en) Anti-cd22 antibody-maytansine conjugates and methods of use thereof
MX2015016332A (en) Pyrrolotriazines as alk inhibitors.
MX2013014488A (en) Methods and compositions for treating brain cancer.
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia
MX2015012523A (en) Methods of making cancer compositions.
IN2013DE03665A (en)
MX2015012610A (en) Deuterated pacritinib.
IN2013DE02958A (en)
UA91886U (en) 1-tert-butoxy-3-(2,2,6,6-tetramethyl-4-hydroxypiperidino)-2-propanol
IN2013DE03592A (en)
IN2013CH05395A (en)
UA87254U (en) Compound 1,1-diethylcarboxy-2-methoxy-2-trifluoromethylethylene with potential physiological properties
UA89447U (en) Compound 1,1-diethylcarboxy-2-chloro- 2-trifluoromethylethylene with potential physiological properties